324 related articles for article (PubMed ID: 12662926)
1. Antiviral inhibition of the HIV-1 capsid protein.
Tang C; Loeliger E; Kinde I; Kyere S; Mayo K; Barklis E; Sun Y; Huang M; Summers MF
J Mol Biol; 2003 Apr; 327(5):1013-20. PubMed ID: 12662926
[TBL] [Abstract][Full Text] [Related]
2. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.
Kelly BN; Kyere S; Kinde I; Tang C; Howard BR; Robinson H; Sundquist WI; Summers MF; Hill CP
J Mol Biol; 2007 Oct; 373(2):355-66. PubMed ID: 17826792
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Maturation: Lessons Learned from Inhibitors.
Kleinpeter AB; Freed EO
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
6. Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.
Abdurahman S; Végvári A; Youssefi M; Levi M; Höglund S; Andersson E; Horal P; Svennerholm B; Balzarini J; Vahlne A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3737-44. PubMed ID: 18644965
[TBL] [Abstract][Full Text] [Related]
7. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
8. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
Thenin-Houssier S; Valente ST
Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
Spearman P
Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
[TBL] [Abstract][Full Text] [Related]
11. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
[TBL] [Abstract][Full Text] [Related]
13. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
[TBL] [Abstract][Full Text] [Related]
14. Functional surfaces of the human immunodeficiency virus type 1 capsid protein.
von Schwedler UK; Stray KM; Garrus JE; Sundquist WI
J Virol; 2003 May; 77(9):5439-50. PubMed ID: 12692245
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
von Schwedler UK; Stemmler TL; Klishko VY; Li S; Albertine KH; Davis DR; Sundquist WI
EMBO J; 1998 Mar; 17(6):1555-68. PubMed ID: 9501077
[TBL] [Abstract][Full Text] [Related]
16. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
Jiang Y; Liu XY
Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
[TBL] [Abstract][Full Text] [Related]
17. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
[TBL] [Abstract][Full Text] [Related]
18. An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation.
Schur FK; Obr M; Hagen WJ; Wan W; Jakobi AJ; Kirkpatrick JM; Sachse C; Kräusslich HG; Briggs JA
Science; 2016 Jul; 353(6298):506-8. PubMed ID: 27417497
[TBL] [Abstract][Full Text] [Related]
19. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein.
Bartonova V; Igonet S; Sticht J; Glass B; Habermann A; Vaney MC; Sehr P; Lewis J; Rey FA; Kraüsslich HG
J Biol Chem; 2008 Nov; 283(46):32024-33. PubMed ID: 18772135
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
